§ Funding Round
Series U funding round for Remix Therapeutics raising $60M in January 2024
Series U funding round for Remix Therapeutics raising $60M in January 2024
| Investor | Firm Type | Partner |
|---|---|---|
Access Biotechnology | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
RA Capital | — | — |
SoftBank Investment Advisers | — | — |
The Column GroupLEAD | Organization | — |
| Angel | josh resnick | |
| Angel | shane neman | |
| Angel | zachary hargreaves | |
| Organization | — | |
| Organization | — | |
Surveyor Capital | — | — |
Willett Advisors | — | — |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$271M
Top Valuation
-
Remix Therapeutics raised $60M in a Series U round.
The round was announced on 01/01/24.
The round was led by The Column Group.
